Reports

Ideas That Generate Results

List of Figures:

Figure 2-1: Population (Million), 2007-2010
Figure 2-2: Life Expectancy of Male & Female (Years), 2005-2010
Figure 2-3: Share of Young & Old Age Population in Total Population (2004-2010)
Figure 2-4: Number of Doctors (per ‘000 Population), 2005-2010
Figure 2-5: Share of Healthcare Expenditure in GDP (2007-2010)
Figure 2-6: Per Head Healthcare Expenditure (US$), 2007-2010
Figure 3-1: Pharmaceutical Market (Billion RUB), 2007-2010
Figure 3-2: Pharmaceutical Market Breakup by Segment (%), 2007-2010
Figure 3-3: Forecast for Pharmaceutical Market (Billion RUB), 2011-2013
Figure 3-4: Forecast for Pharmaceutical Market by Segment (%), 2013
Figure 3-5: Global - Top Pharmaceutical Retail Markets (Billion US$), 2009
Figure 3-6: Global - Per Head Drug Consumption in Top Pharmaceutical Markets (US$), 2009
Figure 3-7: Share of Rx & OTC Drugs in Out-of-Pocket Expenditure (2009)
Figure 3-8: Share of Local & Imported Drugs in Out-of-Pocket Expenditure (2009)
Figure 3-9: Commercial Drugs Market (Billion RUB), 2008-2010
Figure 3-10: Forecast for Commercial Drugs Market (Billion RUB), 2011-2013
Figure 3-11: Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Value (2007-2010)
Figure 3-12: Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Volume (2007-2010)
Figure 3-13: Share of RX & OTC Drugs in Commercial Drugs Market by Sales Value (2007-2010)
Figure 3-14: Share of RX & OTC Drugs in Commercial Drugs Market by Sales Volume (2007-2010)
Figure 3-15: Growth of ATC Groups in Commercial Drugs Market (%), 2009
Figure 3-16: Price Index for Drugs in Commercial Drugs Market (%), 2006-2009
Figure 3-17: Price Index for Imported & Domestic Drugs in Commercial Drugs Market (%), 2006-2009
Figure 3-18: Consumer Price Index (%), 2009
Figure 3-19: State Segment of Pharmaceutical Market (Billion RUB), 2007-2010
Figure 3-20: Forecast for State Segment of Pharmaceutical Market (Billion RUB), 2011-2013
Figure 3-21: Disbursement under DLO Program (Billion RUB), 2008-2010
Figure 3-22: Share of Imported & Domestic Drugs under DLO Program by Sales Value (2008-2010)
Figure 3-23: Share of Imported & Domestic Drugs under DLO Program by Sales Volume (2008-2010)
Figure 3-24: Share of RX & OTC Drugs under DLO Program by Sales Value (2008-2010)
Figure 3-25: Share of RX & OTC Drugs under DLO Program by Sales Volume (2008-2010)
Figure 3-26: Share of Imported & Domestic Drugs under Hospital Segment by Sales Value (2008-2010)
Figure 3-27: Share of Imported & Domestic Drugs under Hospital Segment by Sales Volume (2008-2010)
Figure 3-28: Parapharmaceutical Market (Billion RUB), 2008-2010
Figure 3-29: Forecast for Parapharmaceutical Market (Billion RUB), 2011-2013
Figure 3-30: Nutritional Supplements Market (Million US$), 2008-2010
Figure 3-31: Share of Imported & Domestic Nutritional Supplements (2010)
Figure 3-32: Deaths by Circulatory System Diseases (Million), 2002, 2006 & 2010
Figure 3-33: Hepatitis C Market (Million US$), 2009-2013
Figure 3-34: Number of HIV Patients (Million), 2008-2010
Figure 3-35: Number of Diagnosed Diabetes Patients (Million), 2010 & 2030
Figure 3-36: Insulin Market (Million US$), 2007-2010
Figure 3-37: Cancer Deaths (Per 100,000), 2002, 2006 & 2010
Figure 4-1: Number of Clinical Trials Approved (2007-2010)
Figure 4-2: Number of Patients Planned to be recruited in Clinical Trials (2008-2010)
Figure 4-3: Clinical Trials by Therapeutic Area (%), 2009
Figure 4-4: Clinical Trials by Sponsor Country (%), 2009
Figure 5-1: Commercial Drug Sales by Price Category (%), 2008 & 2009
Figure 5-2: Personal Disposable Income (Billion US$), 2009-2013
Figure 5-3: Forecast for Population (Million), 2011-2013

List of Tables:

Table 3-1: Sales Structure of ATC Groups in Commercial Drugs Market (2009)
Table 3-2: Leading Pharmaceutical Companies in Commercial Drugs Market by Sales (Million RUB), 2009
Table 3-3: Leading Drugs in Commercial Drugs Market by Sales (Million RUB), 2009
Table 3-4: Drugs Sales Structure of ATC Groups under DLO Program (2009)
Table 3-5: Leading Pharmaceutical Companies under DLO Program by Sales (Million RUB), 2009
Table 3-6: Leading Drugs under DLO Program by Sales (Million RUB), 2009
Table 3-7: Sales Structure of ATC Groups in Hospital Segment (2009)
Table 3-8: Leading Pharmaceutical Companies by Sales under Hospital Segment (Million RUB), 2009
Table 3-9: Leading Trade Names under Hospital Segment by Sales (Million RUB), 2009
Table 4-1: Number of Clinical Trials by Top Six Sponsors (2009)
Table 7-1: Sanofi-Aventis - Strengths & Weaknesses
Table 7-2: Novartis Pharma ZAO - Strengths & Weaknesses
Table 7-3: Roche Moscow Ltd. - Strengths & Weaknesses
Table 7-4: Farmstandart OAO - Strengths & Weaknesses
Table 7-5: Akrikhin OAO - Strengths & Weaknesses